Approvals/NMPA/Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol

Approved

化学药品

Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol

ASTRAZENECA AB🇨🇳 National Medical Products Administration

Approval Id: 7uciyl7aSHe
Approval Number: H20190062
Generic Name: 布地格福吸入气雾剂
Generic Name En: Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol
Drug Type: 化学药品
Dosage Form: 气雾剂
Strength: 每瓶56揿,每揿含布地奈德160μg、格隆铵7.2μg和富马酸福莫特罗4.8μg
Reg Date: 2019-12-18
Expired Date: 2024-12-17
Company Name: ASTRAZENECA AB
Company Address: SE-151 85 Södertälje，Sweden
Production Company Name: ASTRAZENECA DUNKERQUE PRODUCTION
Production Company Address: 224 avenue de la Dordogne, Dunkerque 59640, France
Company Detail Path: /organization/astrazeneca-ab
Production Company Detail Path: /organization/astrazeneca-dunkerque-production

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 18, 2019

Approval ID

7uciyl7aSHe

Type

化学药品